SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Akums Drugs’ arm starts second production facility at Haridwar manufacturing unit

23 Aug 2024 Evaluate

Akums Drugs and Pharmaceutical’s wholly owned subsidiary -- Akums Healthcare has commenced its second production facility on August 22, 2024 for manufacturing of eye/ear drops, injectable & infusions dosage forms at its manufacturing unit located at Haridwar, Uttarakhand. 

Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.


Akums Drugs & Pharma Share Price

626.20 -10.85 (-1.70%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: